Table 1.

Baseline characteristics, treatment effects, and adverse event rates applied in the base case analysis

Parameter	MiniMed 780G	isCGM plus MDI or CSII
Baseline cohort characteristics, mean (SD)
Age, years	45.8 (15.3)
Diabetes duration, years	22.8 (13.7)
Male, %	53.9
HbA1c, %	7.8 (0.0)
Treatment effects and adverse event rates
HbA1c, %	− 0.5%	0.0%
Severe hypoglycemic event rate, per 100 patient-years	0.0	63.9
Diabetic ketoacidosis event rate, per 100 patient-years	0.0	0.0

HbA1c glycated hemoglobin, SD standard deviation